The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Mixed immunotherapy and chemotherapy of tumors: modeling, applications and biological interpretations
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The biology of human natural killer-cell subsets
Cooper, M. A., Fehniger, T. A., & Caligiuri, M. A. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)02060-9 · Cited by 2,975
Cancer immunotherapy: moving beyond current vaccines
Rosenberg, S. A., Yang, J. C., & Restifo, N. P. (2004) · Nature Medicine · doi:10.1038/nm1100 · Cited by 2,972
Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes
Dudley, M. E., Wunderlich, J. R., Robbins, P. F., Yang, J. C., Hwu, P., Schwartzentruber, D. J., Topalian, S. L., Sherry, R., Restifo, N. P., Hubicki, A. M., et al. (2002) · Science · doi:10.1126/science.1076514 · Cited by 2,823
Role of Bone Marrow-Derived Cells in Presenting MHC Class I-Restricted Tumor Antigens
Huang, A. Y. C., Golumbek, P., Ahmadzadeh, M., Jaffee, E., Pardoll, D., & Levitsky, H. (1994) · Science · doi:10.1126/science.7513904 · Cited by 1,160
Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity
Diefenbach, A., Jensen, E. R., Jamieson, A. M., & Raulet, D. H. (2001) · Nature · doi:10.1038/35093109 · Cited by 1,083 · cited 7×
“Both NK and CD8 þ T cells are capable of killing tumor cells (see, for example, Diefenbach et al., 2001; Kawarada et al., 2001; Germain, 2004).”
InfluentialNonlinear dynamics of immunogenic tumors: Parameter estimation and global bifurcation analysis
Kuznetsov, V. A., Makalkin, I. A., Taylor, M. A., & Perelson, A. S. (1994) · Bulletin of Mathematical Biology · doi:10.1007/bf02460644 · Cited by 1,061
Modeling immunotherapy of the tumor - immune interaction
Kirschner, D., & Panetta, J. C. (1998) · Journal of Mathematical Biology · doi:10.1007/s002850050127 · Cited by 915
Dynamics of T Lymphocyte Responses: Intermediates, Effectors, and Memory Cells
Lanzavecchia, A., & Sallusto, F. (2000) · Science · doi:10.1126/science.290.5489.92 · Cited by 796
(1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-5-448_4 · Cited by 788
Cancer Immunotherapy: A Treatment for the Masses
Blattman, J. N., & Greenberg, P. D. (2004) · Science · doi:10.1126/science.1100369 · Cited by 612
Perelson, A. S., & Weisbuch, G. (1997) · Reviews of Modern Physics · doi:10.1103/revmodphys.69.1219 · Cited by 574
Essential Mathematical Biology
Britton, N. F. (2003) · Springer Undergraduate Mathematics Series · doi:10.1007/978-1-4471-0049-2 · Cited by 506
T cell fitness determined by signal strength
Gett, A. V., Sallusto, F., Lanzavecchia, A., & Geginat, J. (2003) · Nature Immunology · doi:10.1038/ni908 · Cited by 473
Machiels, J.-P., Reilly, R. T., Emens, L. A., Ercolini, A. M., Lei, R. Y., Weintraub, D., Okoye, F. I., & Jaffee, E. M. (2001) · PubMed · Cited by 453
Pardoll, D. M. (1998) · Nature Medicine · doi:10.1038/nm0598supp-525 · Cited by 428
A Mathematical Tumor Model with Immune Resistance and Drug Therapy: An Optimal Control Approach
De Pillis, L. G., & Radunskaya, A. (2001) · Computational and Mathematical Methods in Medicine · doi:10.1080/10273660108833067 · Cited by 425
Self-citationThe dynamics of an optimally controlled tumor model: A case study
De Pillis, L. G., & Radunskaya, A. (2003) · Mathematical and Computer Modelling · doi:10.1016/s0895-7177(03)00133-x · Cited by 413
Self-citationThe glycolytic phenotype in carcinogenesis and tumor invasion: insights through mathematical models.
Gatenby, R. A., & Gawlinski, E. T. (2003) · PubMed · Cited by 364
Cancer Immunotherapy Using Interleukin-2 and Interleukin-2-Activated Lymphocytes
Rosenberg, S. A., & Lotze, M. T. (1986) · Annual Review of Immunology · doi:10.1146/annurev.iy.04.040186.003341 · Cited by 314
Bellomo, N., & Preziosi, L. (2000) · Mathematical and Computer Modelling · doi:10.1016/s0895-7177(00)00143-6 · Cited by 301
Clinical Responsiveness of Glioblastoma Multiforme to Chemotherapy after Vaccination
Wheeler, C. J., Das, A., Liu, G., Yu, J. S., & Black, K. L. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0497 · Cited by 266
An integrated view of suppressor T cell subsets in immunoregulation
Jiang, H., & Chess, L. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200423411 · Cited by 251
Reaction-diffusion model for the growth of avascular tumor
Ferreira, S. C., Martins, M. L., & Vilela, M. J. (2002) · Physical Review E · doi:10.1103/physreve.65.021907 · Cited by 247
Viruses as antitumor weapons: defining conditions for tumor remission.
Wodarz, D. (2001) · PubMed · Cited by 234
Kawarada, Y., Ganss, R., Garbi, N., Sacher, T., Arnold, B., & Hämmerling, G. J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.9.5247 · Cited by 220
Wein, L. M., Wu, J. T. K., & Kirn, D. H. (2003) · PubMed · Cited by 217
O'Byrne, K. J., Dalgleish, A. G., Browning, M. J., Steward, W. P., & Harris, A. L. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00241-5 · Cited by 206
CD4+CD25+ T Regulatory Cells, Immunotherapy of Cancer, and Interleukin-2
Antony, P. A., & Restifo, N. P. (2005) · Journal of Immunotherapy · doi:10.1097/01.cji.0000155049.26787.45 · Cited by 205
Tumors as elusive targets of T-cell-based active immunotherapy
Marincola, F. M., Wang, E., Herlyn, M., Seliger, B., & Ferrone, S. (2003) · Trends in Immunology · doi:10.1016/s1471-4906(03)00116-9 · Cited by 202
Farrar, J. D., Katz, K. H., Windsor, J., Thrush, G. R., Scheuermann, R. H., Uhr, J. W., & Street, N. E. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.5.2842 · Cited by 178
Glas, R., Franksson, L., Une, C., Eloranta, M., Öhlén, C., Örn, A., & Kärre, K. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.1.129 · Cited by 172
Modeling tumor regrowth and immunotherapy
Kuznetsov, V. A., & Knott, G. D. (2001) · Mathematical and Computer Modelling · doi:10.1016/s0895-7177(00)00314-9 · Cited by 168
Chronic immune activation and inflammation in the pathogenesis of aids and cancer
(2002) · Advances in Cancer Research · doi:10.1016/s0065-230x(02)84008-8 · Cited by 166
An innately interesting decade of research in immunology
Germain, R. N. (2004) · Nature Medicine · doi:10.1038/nm1159 · Cited by 157
Farrar, J. D., Katz, K. H., Windsor, J. A., Thrush, G. R., Scheuermann, R. H., Uhr, J. W., & Street, N. E. (1999) · PubMed · Cited by 147
Bellomo, N., Bellouquid, A., & Delitala, M. E. (2004) · Mathematical Models and Methods in Applied Sciences · doi:10.1142/s0218202504003799 · Cited by 139
IL-12 Enhances CD8 T Cell Homeostatic Expansion
Kieper, W. C., Prlic, M., Schmidt, C. S., Mescher, M. F., & Jameson, S. C. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.9.5515 · Cited by 129
Gardner, S. N. (2000) · PubMed · Cited by 126
Keil, D. E., Luebke, R. W., & Pruett, S. B. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.8.4543 · Cited by 118
Immune Recovery in Children With Malignancy After Cessation of Chemotherapy
Mustafa, M. M., Buchanan, G. R., Winick, N. J., et al. (1998) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-199809000-00008 · Cited by 108
Analysis of a mathematical model for the growth of tumors under the action of external inhibitors
Cui, S. (2002) · Journal of Mathematical Biology · doi:10.1007/s002850100130 · Cited by 105
Müller, M., Gounari, F., Prifti, S., Hacker, H. J., Schirrmacher, V., & Khazaie, K. (1998) · PubMed · Cited by 97
Optimal control of innate immune response
Stengel, R. F., Ghigliazza, R. M., Kulkarni, N. V., & Laplace, O. (2002) · Optimal Control Applications and Methods · doi:10.1002/oca.704 · Cited by 90
Behavior of tumors under nonstationary therapy
Sotolongo-Costa, O., Molina, L. M., Pérez, D. R., Antoranz, J. C., & Reyes, M. C. (2003) · Physica D Nonlinear Phenomena · doi:10.1016/s0167-2789(03)00005-8 · Cited by 88
MATHEMATICAL MODELLING OF MACROPHAGE DYNAMICS IN TUMOURS
Owen, M. R., & Sherratt, J. A. (1999) · Mathematical Models and Methods in Applied Sciences · doi:10.1142/s0218202599000270 · Cited by 81
Gilbertson, S. M., Shah, P. D., & Rowley, D. A. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.10.3567 · Cited by 68
Cell death and the maintenance of immunological memory
Yates, A. J., & Callard, R. E. (2001) · Discrete and Continuous Dynamical Systems - B · doi:10.3934/dcdsb.2001.1.43 · Cited by 59
Friedrich, S. W., Linz, S. C., Stoll, B. R., Baxter, L. T., Munn, L. L., & Jain, R. K. (2002) · Neoplasia · doi:10.1038/sj.neo.7900260 · Cited by 59
Mathematical models of the balance between apoptosis and proliferation
Hardy, K., & Stark, J. (2002) · APOPTOSIS · doi:10.1023/a:1016183731694 · Cited by 52
Cells behaving badly: a theoretical model for the Fas/FasL system in tumour immunology
Webb, S. D., Sherratt, J. A., & Fish, R. G. (2002) · Mathematical Biosciences · doi:10.1016/s0025-5564(02)00120-7 · Cited by 41
ANALYSIS OF A NEW MODEL FOR TUMOR-IMMUNE SYSTEM COMPETITION INCLUDING LONG-TIME SCALE EFFECTS
DERBEL, L. (2004) · Mathematical Models and Methods in Applied Sciences · doi:10.1142/s0218202504003738 · Cited by 40
Dendritic cells: In the forefront of immunopathogenesis and vaccine development – A review
Mohamadzadeh, M., & Luftig, R. B. (2004) · Journal of Immune Based Therapies and Vaccines · doi:10.1186/1476-8518-2-1 · Cited by 33
Toward Cultural Oncology: The Evolutionary Information Dynamics of Cancer
Wallace, R., Wallace, D., & Wallace, R. G. (2003) · Open Systems & Information Dynamics · doi:10.1023/a:1024662223398 · Cited by 31
A dynamical perspective of CTL cross-priming and regulation: implications for cancer immunology
Wodarz, D., & Jansen, V. A. A. (2003) · Immunology Letters · doi:10.1016/s0165-2478(03)00023-3 · Cited by 31
Dudley, M. E., Sundberg, J. P., & Roopenian, D. C. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960117)65:2<204::aid-ijc13>3.0.co;2-d · Cited by 18
Osada, T., Nagawa, H., & Shibata, Y. (2004) · Journal of Immune Based Therapies and Vaccines · doi:10.1186/1476-8518-2-7 · Cited by 17
Critical analysis and perspectives on kinetic (cellular) theory of immune competition
Delitala, M. E. (2002) · Mathematical and Computer Modelling · doi:10.1016/s0895-7177(01)00149-2 · Cited by 11
Alemtuzumab in B-Cell Chronic Lymphocytic Leukemia
Shapira, I., & Grossbard, M. L. (2004) · Clinical Lymphoma · doi:10.1016/s1526-9655(11)70038-0 · Cited by 4
Cited by
Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments
Grauer, O. M., Wesseling, P., & Adema, G. J. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2009.00315.x · Cited by 4,007
ON THE FOUNDATIONS OF CANCER MODELLING: SELECTED TOPICS, SPECULATIONS, AND PERSPECTIVES
BELLOMO, N., LI, N. K., & MAINI, P. K. (2008) · Mathematical Models and Methods in Applied Sciences · doi:10.1142/s0218202508002796 · Cited by 420
Baleanu, D., Jajarmi, A., Sajjadi, S. S., & Mozyrska, D. (2019) · Chaos: An Interdisciplinary Journal of Nonlinear Science · doi:10.1063/1.5096159 · Cited by 357
Reinforcement learning design for cancer clinical trials
Zhao, Y., Kosorok, M. R., & Zeng, D. (2009) · Statistics in Medicine · doi:10.1002/sim.3720 · Cited by 271
Computational Approaches in Theranostics: Mining and Predicting Cancer Data
Cova, T. F. G. G., Bento, D. J., & Nunes, S. C. C. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11030119 · Cited by 32
Metadata
- Authors
- de Pillis, L. G., Gu, W., & Radunskaya, A. E.
- Venue
- Journal of Theoretical Biology
- Publisher
- Elsevier BV
- Published
- 2006-02
- Volume
- 238
- Issue
- 4
- Pages
- 841-862
- ISSN
- 0022-5193 (ISSN-L)
- OpenAlex
- W2147342239
- Cited by
- 575
- References
- 58
- FWCI
- 11.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.